Nurse Practitioner, Adult Health · Lafayette, LA
NPI
1013291350
Since 2011
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
501 W Saint Mary Blvd Ste 200
Lafayette, LA, 70506
Phone (337) 470-4500
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$868K
4,858 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Shelly S Richard prescribed most often to Medicare patients was Pravastatin Sodium, with 248 prescriptions and refills. In total Shelly S Richard wrote 4,858 Medicare prescriptions that cost $868K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-03-17.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Pravastatin Sodium Generic | 248 | 248 | 25 | $11K |
| Amlodipine Besylate Generic | 220 | 220 | 24 | $6,669 |
| Rosuvastatin Calcium Generic | 180 | 180 | 20 | $18K |
| Gabapentin Generic | 179 | 179 | 21 | $4,283 |
| Duloxetine Hcl Generic | 161 | 161 | 18 | $11K |
| Pantoprazole Sodium Generic | 129 | 129 | 19 | $7,506 |
| Metoprolol Succinate Generic | 129 | 129 | 18 | $2,855 |
| Sertraline Hcl Generic | 120 | 120 | 13 | $6,548 |
| Eliquis Apixaban | 117 | 117 | 18 | $65K |
| Levothyroxine Sodium Generic | 116 | 116 | 12 | $2,944 |
| Furosemide Generic | 95 | 95 | 19 | $967 |
| Potassium Chloride Generic | 90 | 90 | 17 | $1,897 |
| Losartan Potassium Generic | 86 | 86 | 14 | $3,418 |
| Lisinopril Generic | 78 | 78 | 11 | $1,546 |
| Clopidogrel Clopidogrel Bisulfate | 75 | 75 | Under 11 | $6,410 |
Brand drugs: 705 claims; generic drugs: 4,123 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Shelly S Richard were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.